A Web-Based Multimedia Resource for Prescription Opiate Treatment

描述(申请人提供)：处方阿片类药物治疗的网络多媒体资源：流行病学数据清楚地表明，处方阿片类药物的滥用是一个主要的公共卫生问题。丁丙诺啡是一种重要的药物，在治疗依赖处方阿片类药物的个人方面有很大的前景。人们普遍认为，丁丙诺啡的成功治疗需要丁丙诺啡和心理社会咨询/治疗支持的结合。然而，越来越多的证据表明，许多正在接受丁丙诺啡治疗的处方阿片剂成瘾者没有参加任何形式的咨询或治疗。不参加咨询和治疗的原因包括此类服务的额外费用，难以接触到了解丁丙诺啡使用情况的咨询专业人员，以及在寻找时间参加治疗计划方面的后勤困难。世界媒体集团(EOW)与加州大学洛杉矶分校(UCLA)综合药物滥用方案(ISAP)合作，提议开发一个创新的网络资源，以加强对处方阿片剂使用者的丁丙诺啡治疗。该应用程序建议开发内部处方药滥用(IPDA)，这是一个基于Web的处方阿片类药物治疗的多媒体资源。IPDA利用互联网技术的最新进展，将互动视频模块、流媒体视频/动画片段、测验、在线论坛和其他资源整合到一个定制的网站中，允许参与者控制他们何时、何地以及如何体验与治疗相关的内容。这些媒体工具将传达引人入胜的、科学准确的信息，提供基于认知行为治疗原则的行为治疗练习，并通过互动反馈和参与工具促进康复活动。该项目团队将结合EOW由MBA艾米丽·迈耶斯和马萨诸塞州玛丽莎·穆尔特雷德领导的媒体专业知识，以及由加州大学洛杉矶分校ISAP的由马里兰州拉丽莎·穆尼领导的成瘾专家团队。该团队将开发内容、视频和网站应用程序，为丁丙诺啡治疗的患者创建独特的资源。将从两个重要的潜在消费者群体--丁丙诺啡处方医生(N=50)以及目前正在接受丁丙诺啡治疗的患者(N=50)--收集关于IPDA资源价值的数据。将通过重点小组、评分表和问卷收集数据，这些数据涉及IPDA资源的感知有用性、网站上提供的材料的相关性和准确性、创新视频场景的吸引力和好处以及对定价、营销和促销工作的反馈。多媒体网络平台的使用是创新的，而且有证据表明这种产品具有商业前景。IPDA的第二阶段对照试验评估将在第一阶段项目成功之后进行。 与公共卫生的相关性：开发一个可获得的、具有成本效益的网络资源，以加强对处方阿片依赖个人的丁丙诺啡治疗，将改善这一患者群体的治疗反应，并降低与处方阿片成瘾有关的发病率和死亡率。这种干预使丁丙诺啡治疗的患者能够访问一套基于网络的多媒体资源，包括互动视频、动画、小测验、定制的反馈工具和其他资源，这些资源促进(A)符合认知行为治疗原则的知识和技能，(B)丁丙诺啡的益处，以及(C)支持积极康复活动的其他重要成瘾知识。如果成功，该产品有可能减少心理社会支持的重大地理、时间和经济障碍；提供关键的行为和成瘾知识；并改善数千名阿片类药物依赖者的治疗结果。

DESCRIPTION (provided by applicant): A Web-Based Multimedia Resource for Prescription Opiate Treatment: Epidemiological data clearly indicate that the abuse of prescription opiates is a major public health problem. Buprenorphine is an important medication that offers great promise in treating individuals who have become dependent on prescription opiates. It is widely accepted that successful treatment with buprenorphine involves a combination of buprenorphine and psychosocial counseling/therapy support. However, there is growing evidence that many individuals addicted to prescription opiates who are being treated with buprenorphine do not participate in any form of counseling or therapy. Reasons cited for non-participation in counseling and therapy include added cost of such services, difficulty in accessing counseling professionals with knowledge about the use of buprenorphine, and logistical challenges in finding time to attend therapy programs. Eyes of the World Media Group (EOW), in collaboration with UCLA Integrated Substance Abuse Programs (ISAP), proposes to develop an innovative Web-based resource to augment buprenorphine treatment of prescription opiate users. This application proposes to develop Inside Prescription Drug Abuse (IPDA), a Web- based multimedia resource for prescription opiate treatment. IPDA uses recent advances in Internet technology to bring together interactive video modules, streaming video/animation segments, quizzes, an online forum, and other resources in a customized Website that allows participants to control when, where, and how they experience treatment-related content. These media tools will convey engaging, scientifically accurate information, provide behavioral treatment exercises based on cognitive behavioral therapy principles, and promote recovery activities via interactive feedback and engagement tools. The project team will combine the media expertise of EOW led by Emily Meyers, MBA, and Marisa Murgatroyd, MA, with a team of addiction experts from UCLA ISAP led by Larissa Mooney, MD. This team will develop the content, video, and Website applications to create a unique resource for patients in buprenorphine treatment. Data will be collected on the value of the IPDA resource from two important potential consumer groups, buprenorphine-prescribing MDs (N=50) as well as patients (N=50) currently in treatment with buprenorphine. Data will be collected via focus groups, rating scales, and questionnaires on the perceived usefulness of the IPDA resource, the relevance and accuracy of the material presented on the site, the appeal and benefit of the innovative video scenarios, and feedback on pricing, marketing, and promotion efforts. The use of the multimedia Web platform is innovative, and there is evidence of commercial promise with such a product. A Phase II controlled trial evaluation of IPDA would follow a successful Phase I project. PUBLIC HEALTH RELEVANCE: The development of an accessible and cost-effective Web-based resource to augment the buprenorphine treatment of individuals dependent on prescription opiates will improve the treatment response of this patient group and reduce the morbidity and mortality associated with prescription opiate addiction. This intervention allows patients in buprenorphine treatment access to a set of Web-based multi-media resources comprising interactive videos, animations, quizzes, customized feedback tools, and other resources promoting (a) knowledge and skills consistent with the principles of cognitive behavioral therapy, (b) the benefits of buprenorphine, and (c) other important addiction knowledge to support positive recovery activities. If successful, the product has the potential to reduce significant geographic, temporal, and financial barriers to psychosocial support; provide critical behavioral and addiction knowledge; and improve the treatment outcomes of thousands of opioid-dependent individuals.